Massachusetts · 194th Legislature (2025-2026) · Bill
S 2524: An Act to sell naming rights to properties operated by the MCCA
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 2524 is a bill introduced in the Massachusetts Senate on June 2, 2025. According to its official title, it concerns: An Act to sell naming rights to properties operated by the MCCA. Primary sponsor: Joint Committee on State Administration and Regulatory Oversight. It lists 1 additional sponsor. Most recent recorded action (June 2, 2025): Bill reported favorably by committee and referred to the committee on Senate Ways and Means.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Senate, June 2, 2025 -- The committee on State Administration and Regulatory Oversight to whom was referred the petition (accompanied by bill, Senate, No. 2179) of Mark C. Montigny for legislation to sell naming rights to the Boston Convention and Exhibition Center and other properties operated by the MCCA, report the accompanying bill (Senate, No. 2524).
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Joint Committee on State Administration and Regulatory Oversight | Primary sponsor | Not applicable (committee) | — | — |
| Mark Montigny | Co-sponsor | Democratic | Senate | Second Bristol and Plymouth |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Bill reported favorably by committee and referred to the committee on Senate Ways and Means
- New draft of S2179
- Reported from the committee on State Administration and Regulatory Oversight